糖尿病白内障超声乳化摘除人工晶状体植入术分析  

Phacoemulsification and intraocular lens implantation in cataract with diabetes

作　　者：余青松[1] 胡超雄[1] 

机构地区：[1]广东省肇庆医学高等专科学校,526020

出　　处：《临床眼科杂志》2004年第5期410-411,共2页Journal of Clinical Ophthalmology

摘　　要：目的　探讨糖尿病患者白内障超声乳化摘除联合人工晶状体植入术的效果。方法　对 4 1例 (4 5只眼 )糖尿病患者施行白内障超声乳化摘除联合人工晶状体植入术 ,术后观察视力、并发症情况。结果　术后视力 0 .3以上者 35只眼 (77.8% ) ,0 .5以上者 2 5只眼 (5 5 .6 % ) ,≤ 0 .1者 2只眼 (4 .4 % )。结论　糖尿病白内障患者行超声乳化摘除联合人工晶状体植入术切口小、视力恢复快、并发症少、安全有效。Objective To evaluate the therapeutic effect of phacoemulsification(phaco), intraocular lens(IOL) implantation in cataract with diabetes.Methods 41 cases(45 eyes) of cataract with diabetes were received the operation,the postoperative visual acuity、complications were investigated. Results The postoperative visual acuity ≥0.3 was 35 eyes (77.8%),≥0.5 was 25 eyes (55.6%),≤0.1 was 2 eyes (4.4%). Conclusion Phacoemulsification and intraocular lens implantation in cataract with diabetes had the advantadge of small-incision、faster visual recovery and lower complications,it is safety、effective.

关 键 词：白内障超声乳化摘除 并发症 糖尿病患者 人工晶状体植入术 联合 人工晶状体植人术 术后观察 白内障患者 视力恢复 术后视力 

分 类 号：R779.66[医药卫生—眼科] R776.1[医药卫生—临床医学]